Interleukin-1 (IL-1) family of cytokines: Role in Type 2 Diabetes

被引:185
作者
Banerjee, Monisha [1 ]
Saxena, Madhukar [1 ]
机构
[1] Univ Lucknow, Dept Zool, Mol & Human Genet Lab, Lucknow 226007, Uttar Pradesh, India
关键词
Cytokines; IL-1; family; IL-1 gene polymorphisms; Mode of action; Type; 2; Diabetes; GAMMA-INDUCING FACTOR; BETA-CELL APOPTOSIS; HUMAN PANCREATIC-ISLETS; RECEPTOR ACCESSORY PROTEIN; INSULIN-SECRETING CELLS; JUN NH2-TERMINAL KINASE; SIGNAL-TRANSDUCTION; INTERFERON-GAMMA; PROINFLAMMATORY CYTOKINES; INFLAMMATORY CYTOKINES;
D O I
10.1016/j.cca.2012.03.021
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Cytokines are small cell signaling protein molecules which encompass a large and diverse family. They consist of immunomodulating agents such as interleukins and inteferons. Virtually all nucleated cells, especially endo/epithelial cells and macrophages are potent producers of IL-1, IL-6 and TNF-alpha. IL-1 family is a group of cytokines which play a central role in the regulation of immune and inflammatory responses. Type 2 diabetes (T2D) has been recognized as an immune mediated disease leading to impaired insulin signaling and selective destruction of insulin producing beta-cells in which cytokines play an important role. Disturbance of anti-inflammatory response could be a critical component of the chronic inflammation resulting in T2D. IL-1 family of cytokines has important roles in endocrinology and in the regulation of responses associated with inflammatory stress. The IL-1 family consists of two pro-inflammatory cytokines, IL-1 alpha and IL-1 beta, and a naturally occurring anti-inflammatory agent, the IL-1 receptor antagonist (IL-1Ra or IL-1RN). This review is an insight into the different types of cytokines belonging to IL-1 family, their modes of action and association with Type 2 diabetes. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1163 / 1170
页数:8
相关论文
共 151 条
[1]
Association of low-grade inflammation with nephropathy in type 2 diabetic patients: Role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines [J].
Abrahamian, H. ;
Endler, G. ;
Exner, M. ;
Mauler, H. ;
Raith, M. ;
Endler, L. ;
Rumpold, H. ;
Gerdov, M. ;
Mannhalter, C. ;
Prager, R. ;
Irsigler, K. ;
Wagner, O. F. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (01) :38-41
[2]
Genetic association of interleukin-1β (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians [J].
Achyut, B. R. ;
Srivastava, Akanksha ;
Bhattacharya, Sandeep ;
Mittal, Balraj .
CLINICA CHIMICA ACTA, 2007, 377 (1-2) :163-169
[3]
The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells [J].
Ammendrup, A ;
Maillard, A ;
Nielsen, K ;
Andersen, NA ;
Serup, P ;
Madsen, OD ;
Mandrup-Poulsen, T ;
Bonny, C .
DIABETES, 2000, 49 (09) :1468-1476
[4]
Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study [J].
Araki, S. ;
Haneda, M. ;
Koya, D. ;
Sugimoto, T. ;
Isshiki, K. ;
Chin-Kanasaki, M. ;
Uzu, T. ;
Kashiwagi, A. .
DIABETOLOGIA, 2007, 50 (04) :867-873
[5]
AREND W P, 1990, Progress in Growth Factor Research, V2, P193, DOI 10.1016/0955-2235(90)90018-F
[6]
Interleukin-1 receptor antagonist: Role in biology [J].
Arend, WP ;
Malyak, M ;
Guthridge, CJ ;
Gabay, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :27-55
[7]
INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY [J].
AREND, WP .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1445-1451
[8]
Association of an IL-1A 3′UTR polymorphism with end-stage renal disease and IL-1α expression [J].
Bensen, JT ;
Langefeld, CD ;
Li, LW ;
McCall, CE ;
Cousart, SL ;
Dryman, BN ;
Freedman, BI ;
Bowden, DW .
KIDNEY INTERNATIONAL, 2003, 63 (04) :1211-1219
[9]
Bianchi M, 1998, J NEUROSCI RES, V53, P645, DOI 10.1002/(SICI)1097-4547(19980915)53:6<645::AID-JNR2>3.0.CO
[10]
2-5